Market closed
Bioventus/$BVS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bioventus
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Ticker
$BVS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,030
Website
Bioventus Metrics
BasicAdvanced
$688M
Market cap
-
P/E ratio
-$0.62
EPS
0.88
Beta
-
Dividend rate
Price and volume
Market cap
$688M
Beta
0.88
52-week high
$13.48
52-week low
$3.90
Average daily volume
336K
Financial strength
Current ratio
1.412
Quick ratio
0.78
Long term debt to equity
194.07
Total debt to equity
216.809
Interest coverage (TTM)
0.78%
Management effectiveness
Return on assets (TTM)
2.48%
Return on equity (TTM)
-24.76%
Valuation
Price to revenue (TTM)
1.212
Price to book
4.62
Price to tangible book (TTM)
-2.51
Price to free cash flow (TTM)
23.742
Growth
Revenue change (TTM)
10.40%
Earnings per share change (TTM)
-78.86%
3-year revenue growth (CAGR)
11.63%
3-year earnings per share growth (CAGR)
79.79%
What the Analysts think about Bioventus
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bioventus stock.
Bioventus Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Bioventus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Bioventus News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bioventus stock?
Bioventus (BVS) has a market cap of $688M as of December 21, 2024.
What is the P/E ratio for Bioventus stock?
The price to earnings (P/E) ratio for Bioventus (BVS) stock is 0 as of December 21, 2024.
Does Bioventus stock pay dividends?
No, Bioventus (BVS) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next Bioventus dividend payment date?
Bioventus (BVS) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioventus?
Bioventus (BVS) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.